(Yicai) Jan. 28 -- Chinese medical researchers have made a breakthrough in gene therapy that overcomes the limitations of ...

A new study has brought scientists one step further in the direction of developing a cure for a brutal group of rare brain disorders known as SYNGAP1-related disorders, or SRDs. Researchers were able ...

A new form of gene therapy designed to treat the most treatment-resistant form of childhood epilepsy appears to reduce seizures in mice. In a research article published Dec. 14 in Brain, researchers ...

Focal cortical dysplasia is caused by areas of the brain that have developed abnormally and is among the most common causes of drug-resistant epilepsy in children. It frequently occurs in the frontal ...

London-based medical device manufacturer LivaNova has announced FDA approval of its most recent Vagus Nerve Stimulation Therapy (VNS Therapy) System, which will be the smallest and lightest responsive ...

Compared with children with epilepsy who received assessment-enhanced usual care, those who received MICE therapy demonstrated improved symptoms of emotional and behavioral difficulties. Young ...

Please provide your email address to receive an email when new articles are posted on . CHICAGO – For persons with epilepsy, cognitive impairment was reduced for those with the generalized form of the ...

Neuroscientist Professor Sonja Bröer from Freie Universität Berlin is involved in the development of an innovative treatment option for therapy-resistant epilepsy. Together with colleagues, ...

Q: I need to learn more about seizures. My father has had grand mal seizures in the past and now is having trouble getting a driver's license. -- O.T., Canton, Ohio A: A seizure is a sudden, transient ...

The NHS is rolling out a new laser treatment for epilepsy that offers a less invasive alternative to conventional neurosurgery. The technique, MRI-guided laser interstitial thermal therapy (LITT), is ...

An experimental neural cell therapy is safe and led to greater than 90% reduction in seizures in two patients with drug-resistant mesial temporal lobe epilepsy (MTLE) in the first-in-human test of the ...